Identification and validation of a novel ferroptosis-related gene model for predicting the prognosis of gastric cancer patients.

<h4>Background</h4>Ferroptosis is a novel form of regulated cell death that plays a critical role in tumorigenesis. The purpose of this study was to establish a ferroptosis-associated gene (FRG) signature and assess its clinical outcome in gastric cancer (GC).<h4>Methods</h4>...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gang Liu, Jian-Ying Ma, Gang Hu, Huan Jin
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/ea840b19598643fcbaa6912de2f53c53
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ea840b19598643fcbaa6912de2f53c53
record_format dspace
spelling oai:doaj.org-article:ea840b19598643fcbaa6912de2f53c532021-12-02T20:09:15ZIdentification and validation of a novel ferroptosis-related gene model for predicting the prognosis of gastric cancer patients.1932-620310.1371/journal.pone.0254368https://doaj.org/article/ea840b19598643fcbaa6912de2f53c532021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0254368https://doaj.org/toc/1932-6203<h4>Background</h4>Ferroptosis is a novel form of regulated cell death that plays a critical role in tumorigenesis. The purpose of this study was to establish a ferroptosis-associated gene (FRG) signature and assess its clinical outcome in gastric cancer (GC).<h4>Methods</h4>Differentially expressed FRGs were identified using gene expression profiles from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) database. Univariate and least absolute shrinkage and selection operator (LASSO) Cox regression analyses were performed to construct a prognostic signature. The model was validated using an independent GEO dataset, and a genomic-clinicopathologic nomogram integrating risk scores and clinicopathological features was established.<h4>Results</h4>An 8-FRG signature was constructed to calculate the risk score and classify GC patients into two risk groups (high- and low-risk) according to the median value of the risk score. The signature showed a robust predictive capacity in the stratification analysis. A high-risk score was associated with advanced clinicopathological features and an unfavorable prognosis. The predictive accuracy of the signature was confirmed using an independent GSE84437 dataset. Patients in the two groups showed different enrichment of immune cells and immune-related pathways. Finally, we established a genomic-clinicopathologic nomogram (based on risk score, age, and tumor stage) to predict the overall survival (OS) of GC patients.<h4>Conclusions</h4>The novel FRG signature may be a reliable tool for assisting clinicians in predicting the OS of GC patients and may facilitate personalized treatment.Gang LiuJian-Ying MaGang HuHuan JinPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 7, p e0254368 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Gang Liu
Jian-Ying Ma
Gang Hu
Huan Jin
Identification and validation of a novel ferroptosis-related gene model for predicting the prognosis of gastric cancer patients.
description <h4>Background</h4>Ferroptosis is a novel form of regulated cell death that plays a critical role in tumorigenesis. The purpose of this study was to establish a ferroptosis-associated gene (FRG) signature and assess its clinical outcome in gastric cancer (GC).<h4>Methods</h4>Differentially expressed FRGs were identified using gene expression profiles from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) database. Univariate and least absolute shrinkage and selection operator (LASSO) Cox regression analyses were performed to construct a prognostic signature. The model was validated using an independent GEO dataset, and a genomic-clinicopathologic nomogram integrating risk scores and clinicopathological features was established.<h4>Results</h4>An 8-FRG signature was constructed to calculate the risk score and classify GC patients into two risk groups (high- and low-risk) according to the median value of the risk score. The signature showed a robust predictive capacity in the stratification analysis. A high-risk score was associated with advanced clinicopathological features and an unfavorable prognosis. The predictive accuracy of the signature was confirmed using an independent GSE84437 dataset. Patients in the two groups showed different enrichment of immune cells and immune-related pathways. Finally, we established a genomic-clinicopathologic nomogram (based on risk score, age, and tumor stage) to predict the overall survival (OS) of GC patients.<h4>Conclusions</h4>The novel FRG signature may be a reliable tool for assisting clinicians in predicting the OS of GC patients and may facilitate personalized treatment.
format article
author Gang Liu
Jian-Ying Ma
Gang Hu
Huan Jin
author_facet Gang Liu
Jian-Ying Ma
Gang Hu
Huan Jin
author_sort Gang Liu
title Identification and validation of a novel ferroptosis-related gene model for predicting the prognosis of gastric cancer patients.
title_short Identification and validation of a novel ferroptosis-related gene model for predicting the prognosis of gastric cancer patients.
title_full Identification and validation of a novel ferroptosis-related gene model for predicting the prognosis of gastric cancer patients.
title_fullStr Identification and validation of a novel ferroptosis-related gene model for predicting the prognosis of gastric cancer patients.
title_full_unstemmed Identification and validation of a novel ferroptosis-related gene model for predicting the prognosis of gastric cancer patients.
title_sort identification and validation of a novel ferroptosis-related gene model for predicting the prognosis of gastric cancer patients.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/ea840b19598643fcbaa6912de2f53c53
work_keys_str_mv AT gangliu identificationandvalidationofanovelferroptosisrelatedgenemodelforpredictingtheprognosisofgastriccancerpatients
AT jianyingma identificationandvalidationofanovelferroptosisrelatedgenemodelforpredictingtheprognosisofgastriccancerpatients
AT ganghu identificationandvalidationofanovelferroptosisrelatedgenemodelforpredictingtheprognosisofgastriccancerpatients
AT huanjin identificationandvalidationofanovelferroptosisrelatedgenemodelforpredictingtheprognosisofgastriccancerpatients
_version_ 1718375157330870272